Skip to main content

Animations

MJFF Publications

4831 - 4840 of 6422 Results
Title
Year
  • Year
  • 2019
  • 2018
  • 2020
  • 2025
  • 2025
  • 2021
  • 2023
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Pink1 −/− Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem Pathology
    Journal Name: Dysphagia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00455-018-9896-5
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28319
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01049-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 91
  • Summary Details
    OPEN
    Title: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschembio.2c00868
    Citation Count: 13
  • Summary Details
    OPEN
    Title: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ange.202309306
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.